Top Markets
Coin of the day
TheraVet S.A. TheraVet S.A.

TheraVet S.A.

ALVET
Rank in Stocks #40004
TheraVet S.A. operates as a veterinary biotechnology firm, delivering... TheraVet S.A. operates as a veterinary biotechnology firm, delivering specialized osteoarticular therapies for animals across Belgium, France, Switzerland, the United Kingdom, and the United States. The company's primary focus is on providing solutions for osteoarthritis, ligament and tendon damage, and bone surgery requirements in felines, canines, and equines. Its product lineup includes BIOCERA-VET, formulated to enhance bone integration and remodeling, and VISCO-VET. The latter is an injectable, hyaluronic acid-based gel that facilitates regeneration, exhibits anti-inflammatory characteristics, boosts the effectiveness of active compounds, and promotes cellular colonization essential for tissue repair. Founded in 2017, TheraVet S.A. has its corporate base situated in Jumet, Belgium.
Share Price
$0.08585084
Last synced: 2025-02-24
Market Cap
$276.78K
Change (1 day)
0.05%
Change (1 year)
0.00%
Country
BE
Trade TheraVet S.A. (ALVET)

Category

EPS for TheraVet S.A. (ALVET)
EPS as of 2026 TTM: 0
According to TheraVet S.A. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for TheraVet S.A. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE